BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for IMx Sirolimus from Abbott

Product group In-vitro diagnostics
Reference 00024/07

Corrective action of Abbott for IMx Sirolimus because of a value shift after sample storage between 2°C and 8°C or freezing. Customers were informed about the problem and how to avoid it.

Corrective action for IMx Sirolimus from Abbott , Download_VeroeffentlichtAm_EN PDF, 88KB, File does not meet accessibility standards